N@N

CVGW, WPI, NKE, SNIC, ACL, ZOLL Are Seasonally Ripe To Go Higher In The Next 4 Weeks

^{Published on 2010-08-30 13:13:55, Last Modified on 2010-12-22 18:51:45 - WOPRAI}
 

August 30, 2010 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Calavo Growers (NASDAQ: CVGW), Watson Pharmaceuticals (NYSE: WPI), Nike (NYSE: NKE), Sonic Solutions (NASDAQ: SNIC), Alcon (NYSE: ACL) and Zoll Medical (NASDAQ: ZOLL) and each have a high seasonal probability to go higher in the next 5 weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go higher:

Symbol Company Expected Return Odds Trading Days

CVGW Calavo Growers Inc. 5.70% 88% (7 of 8) 15

WPI Watson Pharmaceuticals 5.67% 82% (14 of 17) 22

NKE Nike Inc. CL B 5.66% 67% (18 of 27) 24

SNIC Sonic Solutions 5.63% 75% (12 of 16) 9

ACL Alcon Inc 5.56% 75% (6 of 8) 19

ZOLL Zoll Medical Corp 5.55% 72% (13 of 18) 16

Calavo Growers, Inc. (NASDAQ: CVGW) engages in the procurement and marketing of avocados and other perishable commodities, as well as in the preparation and distribution of processed avocado products worldwide. It operates through two segments, Fresh Products and Processed Products. The Fresh Products segment engages in the procurement of avocados grown in Chile, Mexico, and Peru, as well as various other commodities, including tomatoes, papayas, mushrooms, and pineapples. The Processed Products segment processes avocados into various guacamole products, as well as distributes the processed products comprising frozen and cold pasteurized fresh guacamole products. The company sells its products to food distributors, produce wholesalers, supermarkets, and restaurants. Calavo Growers, Inc. was founded in 1924 and is headquartered in Santa Paula, California.

Watson Pharmaceuticals, Inc. (NYSE: WPI), a specialty pharmaceutical company, engages in the development, manufacturing, marketing, sale, and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on urology and women's health in the United States and internationally. The company offers its products for therapeutic categories, such as central nervous system, hormones and synthetic substitutes, cardiovascular, nephrology, and gastrointestinal. It operates in three segments: Global Generic, Global Brand, and Distribution. The Global Generic segment develops, manufactures, markets, sells, and distributes generic products, as well as distributes generic versions of third partiesa� brand products. This segment offers various dosage forms, such as oral solids, transdermals, injectables, inhalation products, and transmucosals for indications, including pregnancy prevention, pain management, depression, hypertension, and smoking cessation. The Global Brand segment includes its promoted urology products, such as Rapaflo, Gelnique, and Trelstar; and various non-promoted products. The Distribution segment distributes generic and certain select brand pharmaceutical products manufactured by third parties, as well as by the company, primarily to independent pharmacies, pharmacy chains, pharmacy buying groups, and physiciansa� offices. The company sells its generic and brand pharmaceutical products primarily to drug wholesalers, retailers, and distributors, including national retail drug and food store chains, hospitals, clinics, mail order, government agencies, and managed healthcare providers, such as health maintenance organizations and other institutions. Watson Pharmaceuticals was founded in 1983 and is based in Corona, California.

NIKE, Inc. (NYSE: NKE) designs, develops, and markets footwear, apparel, equipment, and accessory products for men, women, and children worldwide. The company offers footwear in the categories of running, training, basketball, soccer, sport-inspired casual shoes, and kidsa� shoes. It also provides footwear for aquatic activities, baseball, cheerleading, football, golf, lacrosse, outdoor activities, skateboarding, tennis, volleyball, walking, wrestling, and other athletic and recreational uses. In addition, the company sells sports apparel and accessories, sports-inspired lifestyle apparel, and athletic bags and accessory items, as well as apparel with licensed college and professional team and league logos. Further, it offers performance equipment, including bags, socks, sport balls, eyewear, timepieces, electronic devices, bats, gloves, protective equipment, golf clubs, and other equipment designed for sports activities under the NIKE brand name. The company sells its products primarily through its retail stores and e-commerce, retail accounts, independent distributors, franchisees, and licensees. As of May 31, 2010, it operated 346 retail stores in the United States and 343 retail stores internationally. The company was founded in 1964 and is headquartered in Beaverton, Oregon.

Sonic Solutions (NASDAQ: SNIC) engages in the development of products and services that enable the creation and management of digital media content across various technology platforms. It operates in two segments, Roxio Consumer Products and Premium Content. The Roxio Consumer Products segment creates software and services that enable consumers to create, manage, and share personal digital media content on and across a range of connected devices. It offers its products and services under the names of BackonTrack, Backup MyPC, CinePlayer, Crunch, Easy LP to MP3, Easy VHS to DVD, Just!Burn, MyDVD, MyTV To Go, PhotoShow, PhotoSuite, Popcorn, RecordNow, Roxio Copy & Convert, Roxio Creator, Toast, VideoWave, and WinOnCD. The Premium Content segment offers a range of products and services related to the creation and distribution of premium content. This segment provides software under the Scenarist, CineVision, and DVDit product names, as well as Sonic and Roxio Professional brands to motion picture studios, authoring houses, and other professional customers. It also sells, rents, and distributes entertainment content to consumers over the Internet. In addition, this segment develops and licenses software components to consumer electronics companies. The company also licenses technology and intellectual property to other software companies and technology manufacturers for integration into their own products and services. It serves consumers, original equipment manufacturers (OEMs), businesses, and professional optical disc authoring experts and developers. The company distributes its products and services through retailers and distributors, and personal computer and consumer electronics OEMs, as well as through Internet Websites, including www.roxio.com. It has a strategic relationship with MOD Systems Incorporated to provide a multi-platform system for digitally delivering entertainment to retailers. The company was founded in 1986 and is headquartered in Novato, California.

Alcon, Inc. (NYSE: ACL) engages in the development, manufacture, and marketing of pharmaceuticals, surgical equipment and devices, and consumer eye care products to treat primarily diseases and disorders of the eye in the United States and internationally. It offers various prescription ophthalmic pharmaceutical products for glaucoma treatments; anti-infectives, anti-inflammatories, and combination therapies to treat bacterial, viral, and fungal infections of the eye and to control ocular inflammation; products to treat ocular allergies; combination anti-infective/anti-inflammatory products for ear infections; and generic ophthalmic and otic pharmaceutical products. The companya�s ophthalmic surgical products consist of surgical equipment, single-use, and disposable products for cataract surgery; vitreoretinal surgical products; surgical procedure packs; and refractive products. Its consumer eye care products include contact lens care products, such as disinfecting solutions, cleaners, and lens rewetting drops; vision care products, including artificial tears to treat dry eye syndrome and ocular vitamins, as well as dietary supplements, such as Age Related Eye Disease Study Formula, Lutein, and Zeaxanthin formula. The company sells its pharmaceutical products to physicians, distributors, wholesalers, hospitals, government agencies, and large retailers; surgical products directly to hospitals and ambulatory surgical centers, and through distributors; and consumer eye care products directly to retailers and optical chains, as well as to distributors for resale directly to smaller retailers and eye care professionals. It was formerly known as Alcon Universal S.A. and changed its name to Alcon, Inc. in December 2001. The company was founded in 1945 and is based in Hunenberg, Switzerland. Alcon, Inc. is a subsidiary of Nestle S.A.

ZOLL Medical Corporation (NASDAQ: ZOLL), together with its subsidiaries, develops and markets medical devices and software solutions in the United States and internationally. The company provides a set of technologies, including products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, which help clinicians, EMS and fire professionals, and lay rescuers in the treatment of victims needing resuscitation and critical care. Its resuscitation line of products include professional defibrillators, which comprise the M Series, E Series, R Series, and automated external defibrillators (AED) Pro with manual defibrillation capability; AED products for use by trained rescuers, which include the AED Pro and the AED Plus; disposable electrodes used with ZOLLa�s line of defibrillators; the AutoPulse non-invasive sudden cardiac support pumps, used to automate the process of delivering chest compressions; documentation and information management products, including RescueNet for EMS and fire personnel, and Code Net for hospitals; the ZOLL LifeVest, a wearable external defibrillator; and fluid replacement utilizing the Power Infuser in trauma. The company also offers Intravascular Temperature Management products, which include CoolGard 3000, and Thermogard XP temperature management systems and disposable catheters used for ill and surgical patients. In addition, it provides various single-patient-use proprietary disposable electrodes for use with ZOLLa�s line of defibrillators and AEDs. The company markets its products through sales and managerial staff comprising direct representatives and their managers, distribution managers, special account representatives, distributors, and manufacturera�s representatives. ZOLL Medical Corporation was founded in 1980 and is headquartered in Chelmsford, Massachusetts.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 27 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641